Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE3.0500
- TODAY'S CHANGE (%)0.2900 (10.5072%)
- Bid / Lots2.9000/ 1
- Ask / Lots3.0300/ 1
- Open / Previous Close2.7500 / 2.7600
- Day Range
- 52 Week Range
- Volume1,415,816
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 893 | 2.71 |
| 09:36 ET | 100 | 2.71 |
| 09:38 ET | 500 | 2.7103 |
| 09:39 ET | 693 | 2.72 |
| 09:41 ET | 400 | 2.725 |
| 09:45 ET | 300 | 2.73 |
| 09:50 ET | 2567 | 2.75 |
| 09:54 ET | 100 | 2.745 |
| 09:56 ET | 200 | 2.75 |
| 09:57 ET | 5041 | 2.775 |
| 09:59 ET | 1200 | 2.775 |
| 10:01 ET | 18442 | 2.8 |
| 10:03 ET | 8528 | 2.805 |
| 10:06 ET | 12929 | 2.855 |
| 10:08 ET | 39733 | 2.88 |
| 10:10 ET | 3136 | 2.87 |
| 10:12 ET | 34520 | 2.855 |
| 10:14 ET | 6296 | 2.865 |
| 10:15 ET | 9760 | 2.85 |
| 10:17 ET | 4400 | 2.85 |
| 10:19 ET | 536 | 2.84 |
| 10:24 ET | 1063 | 2.845 |
| 10:26 ET | 2430 | 2.85 |
| 10:28 ET | 900 | 2.85 |
| 10:30 ET | 1100 | 2.855 |
| 10:32 ET | 100 | 2.855 |
| 10:33 ET | 400 | 2.855 |
| 10:35 ET | 1900 | 2.85 |
| 10:39 ET | 2653 | 2.8598 |
| 10:44 ET | 900 | 2.865 |
| 10:46 ET | 300 | 2.87 |
| 10:48 ET | 6942 | 2.8699 |
| 10:50 ET | 1500 | 2.8727 |
| 10:51 ET | 300 | 2.87 |
| 10:53 ET | 100 | 2.88 |
| 10:55 ET | 1200 | 2.878 |
| 10:57 ET | 200 | 2.88 |
| 11:00 ET | 100 | 2.88 |
| 11:02 ET | 2872 | 2.8797 |
| 11:08 ET | 500 | 2.875 |
| 11:09 ET | 100 | 2.875 |
| 11:11 ET | 183 | 2.88 |
| 11:18 ET | 850 | 2.8789 |
| 11:22 ET | 1100 | 2.8701 |
| 11:24 ET | 100 | 2.88 |
| 11:26 ET | 300 | 2.875 |
| 11:27 ET | 6560 | 2.905 |
| 11:29 ET | 8188 | 2.89 |
| 11:31 ET | 300 | 2.895 |
| 11:33 ET | 3797 | 2.9 |
| 11:38 ET | 4515 | 2.91 |
| 11:40 ET | 750 | 2.905 |
| 11:42 ET | 800 | 2.91 |
| 11:44 ET | 1500 | 2.905 |
| 11:45 ET | 100 | 2.905 |
| 11:54 ET | 8939 | 2.925 |
| 11:56 ET | 12202 | 2.925 |
| 11:58 ET | 16000 | 2.94 |
| 12:00 ET | 200 | 2.945 |
| 12:02 ET | 3188 | 2.945 |
| 12:05 ET | 10700 | 2.9425 |
| 12:07 ET | 3742 | 2.955 |
| 12:09 ET | 1700 | 2.955 |
| 12:12 ET | 2200 | 2.96 |
| 12:14 ET | 8738 | 2.9611 |
| 12:16 ET | 2100 | 2.97 |
| 12:18 ET | 500 | 2.9692 |
| 12:20 ET | 127364 | 2.9775 |
| 12:21 ET | 23878 | 3.0025 |
| 12:23 ET | 30035 | 3.0166 |
| 12:25 ET | 6958 | 2.9975 |
| 12:27 ET | 1200 | 2.9991 |
| 12:30 ET | 2000 | 3 |
| 12:32 ET | 8896 | 2.9999 |
| 12:34 ET | 46015 | 3.005 |
| 12:36 ET | 6550 | 3 |
| 12:38 ET | 55571 | 2.995 |
| 12:39 ET | 8983 | 3 |
| 12:41 ET | 4315 | 3.01 |
| 12:43 ET | 88167 | 3.0017 |
| 12:45 ET | 91302 | 2.945 |
| 12:48 ET | 12891 | 2.935 |
| 12:50 ET | 9439 | 2.95 |
| 12:52 ET | 12049 | 2.95 |
| 12:54 ET | 5659 | 2.95 |
| 12:56 ET | 16928 | 2.97 |
| 12:57 ET | 6525 | 2.96 |
| 12:59 ET | 3272 | 2.97 |
| 01:01 ET | 12816 | 2.955 |
| 01:03 ET | 7519 | 2.97 |
| 01:06 ET | 28324 | 2.99 |
| 01:08 ET | 5505 | 2.985 |
| 01:10 ET | 9000 | 2.97 |
| 01:12 ET | 600 | 2.975 |
| 01:14 ET | 3070 | 2.965 |
| 01:15 ET | 100 | 2.965 |
| 01:17 ET | 500 | 2.965 |
| 01:19 ET | 200 | 2.96 |
| 01:21 ET | 300 | 2.961 |
| 01:24 ET | 8797 | 2.96 |
| 01:26 ET | 500 | 2.958 |
| 01:28 ET | 5127 | 2.945 |
| 01:30 ET | 5024 | 2.945 |
| 01:32 ET | 4339 | 2.945 |
| 01:33 ET | 100 | 2.945 |
| 01:35 ET | 1550 | 2.95 |
| 01:37 ET | 16159 | 2.975 |
| 01:39 ET | 585 | 2.9769 |
| 01:42 ET | 400 | 2.97 |
| 01:44 ET | 300 | 2.975 |
| 01:48 ET | 100 | 2.975 |
| 01:50 ET | 6586 | 2.985 |
| 01:51 ET | 600 | 2.985 |
| 01:53 ET | 904 | 2.985 |
| 01:55 ET | 4511 | 2.995 |
| 01:57 ET | 11420 | 3 |
| 02:00 ET | 7600 | 3 |
| 02:02 ET | 2205 | 3.0018 |
| 02:04 ET | 350 | 3.0045 |
| 02:06 ET | 11821 | 3.015 |
| 02:08 ET | 4450 | 3.0172 |
| 02:09 ET | 8849 | 3.025 |
| 02:11 ET | 200 | 3.025 |
| 02:15 ET | 100 | 3.025 |
| 02:18 ET | 300 | 3.025 |
| 02:20 ET | 9550 | 3.035 |
| 02:22 ET | 430 | 3.035 |
| 02:24 ET | 1800 | 3.035 |
| 02:26 ET | 14427 | 3.02 |
| 02:27 ET | 727 | 3.025 |
| 02:29 ET | 200 | 3.025 |
| 02:31 ET | 1861 | 3.0222 |
| 02:33 ET | 9975 | 3.01 |
| 02:36 ET | 100 | 3.01 |
| 02:38 ET | 745 | 3.015 |
| 02:40 ET | 1170 | 3.015 |
| 02:44 ET | 11472 | 3.015 |
| 02:45 ET | 1425 | 3.02 |
| 02:47 ET | 202 | 3.015 |
| 02:49 ET | 1455 | 3.0115 |
| 02:51 ET | 100 | 3.01 |
| 02:54 ET | 126 | 3.005 |
| 02:56 ET | 5441 | 2.985 |
| 02:58 ET | 3300 | 2.985 |
| 03:00 ET | 2109 | 2.99 |
| 03:03 ET | 12461 | 3 |
| 03:05 ET | 200 | 3 |
| 03:07 ET | 200 | 3 |
| 03:09 ET | 700 | 2.995 |
| 03:12 ET | 2711 | 3.005 |
| 03:14 ET | 1898 | 3.005 |
| 03:16 ET | 700 | 3.005 |
| 03:18 ET | 1926 | 3 |
| 03:20 ET | 3012 | 3.01 |
| 03:21 ET | 8575 | 3.02 |
| 03:23 ET | 23741 | 3.0382 |
| 03:25 ET | 1065 | 3.035 |
| 03:27 ET | 8995 | 3.04 |
| 03:30 ET | 3227 | 3.0401 |
| 03:32 ET | 7788 | 3.03 |
| 03:34 ET | 100 | 3.04 |
| 03:36 ET | 4898 | 3.045 |
| 03:38 ET | 2521 | 3.045 |
| 03:39 ET | 2002 | 3.05 |
| 03:41 ET | 3879 | 3.05 |
| 03:43 ET | 6349 | 3.05 |
| 03:45 ET | 4300 | 3.055 |
| 03:48 ET | 20891 | 3.05 |
| 03:50 ET | 4620 | 3.0679 |
| 03:52 ET | 21221 | 3.065 |
| 03:54 ET | 18984 | 3.085 |
| 03:56 ET | 5934 | 3.0799 |
| 03:57 ET | 11672 | 3.08 |
| 03:59 ET | 22411 | 3.05 |
Apr 10, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $6.00/Share by Needham, from 6:21AM ET on Wednesday Apr 10, 2024 by Dow Jones
6:21AM ET on Wednesday Apr 10, 2024 by Dow Jones
Apr 3, 2024
Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference, from 7:30AM ET on Wednesday Apr 03, 2024 by Dow Jones
7:30AM ET on Wednesday Apr 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 387.1M | -11.6x | --- |
Allogene Therapeutics Inc | 484.9M | -1.3x | --- |
Nkarta Inc | 485.7M | -2.8x | --- |
Humacyte Inc | 487.1M | -3.7x | --- |
Celcuity Inc | 488.8M | -5.8x | --- |
Cabaletta Bio Inc | 490.5M | -6.4x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Director
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $387.1M |
|---|---|
Revenue (TTM) | $9.0M |
Shares Outstanding | 140.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.82 |
EPS | $-0.26 |
Book Value | $0.62 |
P/E Ratio | -11.6x |
Price/Sales (TTM) | 43.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -444.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
